Table 3. Lipid Screening and Management Among 61 Primary Care Practices in North Carolina.
| Quality Indicator | ATP III Practice | JNC-7 Practice | ATP III–JNC-7 Comparison | P Value |
|---|---|---|---|---|
| Screening | ||||
| Sample size before/after intervention | 2216/1811 | 2841/2010 | ||
| Patients screened, % | ||||
| Baseline | 43.6 | 40.1 | +3.5 | .41 |
| Follow-up | 49.0 | 50.8 | −1.8 | .72 |
| Change from follow-up to baseline | +6.6 | +10.7 | −5.3 | .22 |
| Appropriate management | ||||
| Sample size before/after intervention | 842/709 | 855/771 | ||
| Patients appropriately managed, % | ||||
| Baseline | 73.4 | 79.7 | −6.3 | .02 |
| Follow-up | 72.3 | 68.9 | +3.4 | .18 |
| Change from follow-up to baseline | −1.1 | −0.8 | +9.7 | <.01 |
| Inappropriate prescription of LLT | ||||
| Sample size before/after intervention | 626/519 | 650/571 | ||
| Patients who received inappropriate prescription, % | ||||
| Baseline | 6.6 | 4.2 | +2.4 | .15 |
| Follow-up | 3.9 | 6.4 | −2.5 | .07 |
| Change from follow-up to baseline | −2.7 | +2.2 | −4.9 | .01 |
| Appropriate prescription of LLT | ||||
| Sample size before/after intervention | 216/190 | 205/200 | ||
| Patients who received appropriate prescription, % | ||||
| Baseline | 38.8 | 45.3 | −6.5 | .27 |
| Follow-up | 24.8 | 24.1 | +0.7 | .88 |
| Change from follow-up to baseline | −14.0 | −21.2 | +7.2 | .37 |
Abbreviations: ATP III, Third Adult Treatment Panel; JNC-7, Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; LLT, therapy to lower lipid levels.